L, W., M, G., R, K., MF, B. H. R., DQ, C., WY, C., . . . N, L. (2025). EORTC QLU-C10D was similarly valid and sensitive as EQ-5D-5L but more responsive to cancer patients' health deterioration. Journal of clinical epidemiology, 187, 111965. https://doi.org/10.1016/j.jclinepi.2025.111965
Chicago Style (17th ed.) CitationL, Wang, Gandhi M, Kanesvaran R, Bin Harunal Rashid MF, Chong DQ, Chay WY, Norman R, King MT, and Luo N. "EORTC QLU-C10D Was Similarly Valid and Sensitive as EQ-5D-5L but More Responsive to Cancer Patients' Health Deterioration." Journal of Clinical Epidemiology 187 (2025): 111965. https://doi.org/10.1016/j.jclinepi.2025.111965.
MLA (9th ed.) CitationL, Wang, et al. "EORTC QLU-C10D Was Similarly Valid and Sensitive as EQ-5D-5L but More Responsive to Cancer Patients' Health Deterioration." Journal of Clinical Epidemiology, vol. 187, 2025, p. 111965, https://doi.org/10.1016/j.jclinepi.2025.111965.